A Phase II Trial to Assess the Safety and Efficacy of Hormonal Ablation Plus Estramustine and Docetaxel Combined with Radiotherapy in Locally Advanced or Locally Recurrent, Nonmetastatic Adenocarcinoma of the Prostate

Service: Trial Number:
258-05
Principal Investigator: Conducted at:
Long Beach Medical Center
Currently enrolling additional patients:
Yes
Age Range:
18 & older
Gender:
Male

This is a research study designed for patients who have been diagnosed with a high-risk prostate cancer or your prostate cancer has recurred locally (without spreading to new parts of your body). This clinical research study is to determine whether hormone therapy and low doses of the drugs estramustine and docetaxel combined with radiation therapy will control your cancer.